Medtronic PLC's board approved an 8% increase in the company's dividend to 54 cents per ordinary share for the second quarter of the fiscal year 2020.
The dividend is payable Oct. 18 to shareholders of record as of Sep. 27.
Medtronic sells device-based medical treatments focused on cardiovascular disease, regenerative therapies and diabetes to hospitals and physicians.
